These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16566870)

  • 1. Epilepsy and chromosomal rearrangements in Smith-Magenis Syndrome [del(17)(p11.2p11.2)].
    Goldman AM; Potocki L; Walz K; Lynch JK; Glaze DG; Lupski JR; Noebels JL
    J Child Neurol; 2006 Feb; 21(2):93-8. PubMed ID: 16566870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Duncan WC; Smith AC
    Pediatr Neurol; 2006 May; 34(5):337-50. PubMed ID: 16647992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mosaicism for del(17)(p11.2p11.2) underlying the Smith-Magenis syndrome.
    Juyal RC; Kuwano A; Kondo I; Zara F; Baldini A; Patel PI
    Am J Med Genet; 1996 Dec; 66(2):193-6. PubMed ID: 8958329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epileptology of Koolen-de Vries syndrome: Electro-clinico-radiologic findings in 31 patients.
    Myers KA; Mandelstam SA; Ramantani G; Rushing EJ; de Vries BB; Koolen DA; Scheffer IE
    Epilepsia; 2017 Jun; 58(6):1085-1094. PubMed ID: 28440867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)].
    Potocki L; Shaw CJ; Stankiewicz P; Lupski JR
    Genet Med; 2003; 5(6):430-4. PubMed ID: 14614393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Elsea S; Duncan WC; Smith AC
    Curr Opin Neurol; 2007 Apr; 20(2):125-34. PubMed ID: 17351481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Smith-Magenis syndrome].
    Livet MO; Moncla A; Delobel B; Croquette MF; Philip N; Vallée L
    Arch Pediatr; 1997 Dec; 4(12):1231-7. PubMed ID: 9538429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Speech impairment and the Smith-Magenis syndrome].
    Bergmann C; Morlot S; Ptok M
    HNO; 2007 Aug; 55(8):644-6. PubMed ID: 16767429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective longitudinal overnight video-EEG evaluation in Phelan-McDermid Syndrome.
    Khan OI; Zhou X; Leon J; Kessler R; Gaughan T; D'Souza P; Gropman A; Cohen N; Rennert O; Buckley A; Inati S; Thurm A
    Epilepsy Behav; 2018 Mar; 80():312-320. PubMed ID: 29402632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype.
    Potocki L; Bi W; Treadwell-Deering D; Carvalho CM; Eifert A; Friedman EM; Glaze D; Krull K; Lee JA; Lewis RA; Mendoza-Londono R; Robbins-Furman P; Shaw C; Shi X; Weissenberger G; Withers M; Yatsenko SA; Zackai EH; Stankiewicz P; Lupski JR
    Am J Hum Genet; 2007 Apr; 80(4):633-49. PubMed ID: 17357070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic manifestations of Smith-Magenis syndrome.
    Chen RM; Lupski JR; Greenberg F; Lewis RA
    Ophthalmology; 1996 Jul; 103(7):1084-91. PubMed ID: 8684798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient with large 17p11.2 deletion presenting with Smith-Magenis syndrome and Joubert syndrome phenotype.
    Natacci F; Corrado L; Pierri M; Rossetti M; Zuccarini C; Riva P; Miozzo M; Larizza L
    Am J Med Genet; 2000 Dec; 95(5):467-72. PubMed ID: 11146468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic FISH probes for del(17)(p11.2p11.2) associated with Smith-Magenis syndrome should contain the RAI1 gene.
    Vlangos CN; Wilson M; Blancato J; Smith AC; Elsea SH
    Am J Med Genet A; 2005 Jan; 132A(3):278-82. PubMed ID: 15690371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic hand anomalies in Smith-Magenis syndrome: four new patients with del (17)(p11.2p11.2).
    Kondo I; Matsuura S; Kuwajima K; Tokashiki M; Izumikawa Y; Naritomi K; Niikawa N; Kajii T
    Am J Med Genet; 1991 Nov; 41(2):225-9. PubMed ID: 1785639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally?
    Vlangos CN; Yim DK; Elsea SH
    Mol Genet Metab; 2003 Jun; 79(2):134-41. PubMed ID: 12809645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smith-Magenis syndrome: report of one case.
    Hou JW
    Acta Paediatr Taiwan; 2003; 44(3):161-4. PubMed ID: 14521023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smith-Magenis syndrome.
    Finucane BM; Jaeger ER
    Ophthalmology; 1997 May; 104(5):732-3. PubMed ID: 9160013
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome.
    Yan J; Keener VW; Bi W; Walz K; Bradley A; Justice MJ; Lupski JR
    Hum Mol Genet; 2004 Nov; 13(21):2613-24. PubMed ID: 15459175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smith-Magenis syndrome and Moyamoya disease in a patient with del(17)(p11.2p13.1).
    Girirajan S; Mendoza-Londono R; Vlangos CN; Dupuis L; Nowak NJ; Bunyan DJ; Hatchwell E; Elsea SH
    Am J Med Genet A; 2007 May; 143A(9):999-1008. PubMed ID: 17431895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, cytogenetic, and molecular evidence for an infant with Smith-Magenis syndrome born from a mother having a mosaic 17p11.2p12 deletion.
    Zori RT; Lupski JR; Heju Z; Greenberg F; Killian JM; Gray BA; Driscoll DJ; Patel PI; Zackowski JL
    Am J Med Genet; 1993 Sep; 47(4):504-11. PubMed ID: 8256814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.